Cargando…
Primary central nervous system lymphoma high incidence and poor survival in Finnish population-based analysis
BACKGROUND: We report here the first population-based incidence rates and prognosis of primary central nervous system lymphoma (PCNSL) in Finland. METHODS: Finnish Cancer Registry data by histological diagnosis and tumor location (2007–2017) for cases with diffuse large B-cell lymphoma. RESULTS: Dur...
Autores principales: | Puhakka, Inka, Kuitunen, Hanne, Jäkälä, Pekka, Sonkajärvi, Eila, Turpeenniemi-Hujanen, Taina, Rönkä, Aino, Selander, Tuomas, Korhonen, Miika, Kuittinen, Outi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8895860/ https://www.ncbi.nlm.nih.gov/pubmed/35241020 http://dx.doi.org/10.1186/s12885-022-09315-8 |
Ejemplares similares
-
Significance of bulky mass and residual tumor—Treated with or without consolidative radiotherapy—To the risk of relapse in DLBCL patients
por: Tokola, Susanna, et al.
Publicado: (2020) -
Interim and end‐of‐treatment PET‐CT suffers from high false‐positive rates in DLBCL: Biopsy is needed prior to treatment decisions
por: Tokola, Susanna, et al.
Publicado: (2021) -
Blood–Brain Barrier Disruption (BBBD)-Based Immunochemotherapy for Primary Central Nervous System Lymphoma (PCNSL), Early Results of a Phase II Study
por: Kuitunen, Hanne K., et al.
Publicado: (2023) -
Impact of central nervous system (CNS) prophylaxis on the incidence of CNS relapse in patients with high-risk diffuse large B cell/follicular grade 3B lymphoma
por: Kuitunen, Hanne, et al.
Publicado: (2020) -
Real-time monitoring of human blood-brain barrier disruption
por: Kiviniemi, Vesa, et al.
Publicado: (2017)